Litcius/Paper detail

COVID-19 in a patient with end-stage renal disease on chronic in-center hemodialysis after evidence of SARS-CoV-2 IgG antibodies. Reinfection or inaccuracy of antibody testing

Jair Munoz Mendoza, María L. Alcaide

2020IDCases24 citationsDOIOpen Access PDF

Abstract

A patient with end-stage renal disease on hemodialysis with a previous positive SARS-CoV-2 IgG antibody was diagnosed with severe COVID-19. Issues regarding reinfection, the potential lack of antibody protection after asymptomatic infection, the possibility of antibody dependent enhancement and careful interpretation of antibody test results are discussed.

Topics & Concepts

MedicineAsymptomaticAntibodyHemodialysisEnd stage renal diseaseCoronavirus disease 2019 (COVID-19)ImmunologyDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyInternal medicineInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDiabetes and associated disorders
COVID-19 in a patient with end-stage renal disease on chronic in-center hemodialysis after evidence of SARS-CoV-2 IgG antibodies. Reinfection or inaccuracy of antibody testing | Litcius